Southeast Asian countries have made significant progress in the management of rare disease, but there remain key areas for substantial development opportunities.
No takes yet. Share an insight, caveat, or question.
Shafie et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: